Men's Health News

RSS

Prostate cancer: To screen or not to screen

Men with a family history of prostate cancer who are confused about whether to undergo controversial screening could soon have access to an online resource to have their questions answered.

20 Jul 2010

ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment test

deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE's DNA-based prostate cancer risk assessment test to its clients nationwide.

20 Jul 2010

Failure to seek help for ED could prevent detection of underlying cardiovascular disease

Research carried out by a visiting professor at the University of Hertfordshire has found that up to six million European men fail to seek help for Erectile Dysfunction (ED) which could result in underlying cardiovascular disease going undetected.

20 Jul 2010

PSI to release evidence supporting quality scale-up of male circumcision

Following the remarks on male circumcision made today by former President Bill Clinton and philanthropist Bill Gates, PSI will release the results of a groundbreaking study on a new model of efficiency that will allow for quality and cost-effective scale-up of male circumcision.

20 Jul 2010

CytRx updates on progress in clinical development of bafetinib in three oncology indications

CytRx Corporation, a biopharmaceutical company specializing in oncology, announces progress with its clinical program to evaluate the preliminary efficacy and safety of its drug candidate bafetinib in three oncology indications. The Company has enrolled its first patient in a Phase 2 proof-of-concept trial in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL), is reporting rapid advancement toward the initiation of a Phase 2 proof-of-concept trial in advanced prostate cancer, and is on track to begin clinical evaluation later this year in glioblastoma multiforme, a common and aggressive type of primary brain tumor.

20 Jul 2010

USFDA approves Sun Pharma's generic Flomax ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for its Abbreviated New Drug Application to market a generic version of Flomax ®, tamsulosin capsules.

16 Jul 2010

PSA test reduces prostate cancer death rate by nearly 50%: NCI

The nation's leading authority on cancer has thrown out its own study on prostate cancer screening, now saying that PSA testing reduces the prostate cancer death rate by nearly 50 percent.

16 Jul 2010

Study links high-fat diet as potential cause of prostatic diseases

Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplsia, prostatitis, and prostate cancer.

15 Jul 2010

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

ONCURA, a business unit of GE Healthcare and global leader in the minimally invasive permanent prostate brachytherapy management of prostate cancer, has announced that it has signed an agreement to distribute Theragenics Corporation TheraSeed(R) palladium-103 brachytherapy seeds.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

Study identifies protein that turns non-malignant tumor into metastatic neuroendocrine tumor

Some types of prostate tumors are more aggressive and more likely to metastasize than others. Nearly one-third of these aggressive tumors contain a small nest of especially dangerous cells known as neuroendocrine-type cells. More rarely, some aggressive prostate tumors are made up entirely of neuroendocrine-type cells. The presence of neuroendocrine-type cancer cells is associated with a poor prognosis, but spotting these rare cells can be like finding a needle in a haystack.

13 Jul 2010

SPET-085 is effective in blocking critical enzyme that leads to BPH: Study

A new study, published in the July issue of Advances in Therapy, revealed that a novel saw palmetto extract, SPET-085, is as effective as finasteride, the standard prescription drug therapy, in blocking the critical enzyme that leads to benign prostatic hyperplasia.

13 Jul 2010

Men with prostate cancer lose less bone mineral content as they age: Study

Men with prostate cancer lose significantly less bone mineral content (BMC) as they age than men who are free of the disease, according to research in the July issue of BJUI. The findings are important because loss of BMC can play a key role in the development of fragile bones, fractures and osteoporosis.

13 Jul 2010

Men who enter adult life obese are at increased risk of premature death

Men who enter adult life obese face a life-long doubling of the risk of dying prematurely, new research has found.

13 Jul 2010

GWAS suggests genetic variant with increased oncogene expression for cancer study

The study, published July 13th in Genome Research, showcases a new protocol for studying the activity of cancer-risk variants suggested by GWAS studies. The results also underscore the dramatic consequences of small genetic changes even in the vast stretches of DNA, known as "gene deserts," that do not code for proteins.

13 Jul 2010

Depression increases cardiovascular problems in men with erectile dysfunction

A new study in the Journal of Sexual Medicine found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event.

13 Jul 2010

Differences in response to taste of fat between obese and lean men

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds marked differences between obese and lean men in how they respond to the taste of fat. Fat also is less effective in obese men in stimulating certain gut hormones that are released into the bloodstream and normally suppress appetite.

13 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

Males with faulty BRCA2 genes at risk of breast cancer

Men who carry a faulty version of the BRCA2 gene have an estimated one-in-15 chance of developing breast cancer by the time they reach 70, British scientists have found.

9 Jul 2010

MHN endorses 'The American Journal of Men's Health'

The American Journal of Men's Health (published by SAGE) is now endorsed by Men's Health Network.

9 Jul 2010

Men's Health News

Prostate cancer: To screen or not to screen

ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment test

Failure to seek help for ED could prevent detection of underlying cardiovascular disease

PSI to release evidence supporting quality scale-up of male circumcision

CytRx updates on progress in clinical development of bafetinib in three oncology indications

USFDA approves Sun Pharma's generic Flomax ANDA

PSA test reduces prostate cancer death rate by nearly 50%: NCI

Study links high-fat diet as potential cause of prostatic diseases

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Study identifies protein that turns non-malignant tumor into metastatic neuroendocrine tumor

SPET-085 is effective in blocking critical enzyme that leads to BPH: Study

Men with prostate cancer lose less bone mineral content as they age: Study

Men who enter adult life obese are at increased risk of premature death

GWAS suggests genetic variant with increased oncogene expression for cancer study

Depression increases cardiovascular problems in men with erectile dysfunction

Differences in response to taste of fat between obese and lean men

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Males with faulty BRCA2 genes at risk of breast cancer

MHN endorses 'The American Journal of Men's Health'

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News